To: Arfaa is the Brucella melitensis Rev-1 vaccine as a cause of human brucellosis at The Lancet based in Iran.
To: Arfaa
Brucella melitensis Rev-1 vaccine as a cause of human brucellosis at The Lancet in Iran
Verified profile
t***@thelancet.com
Job Title
Brucella melitensis Rev-1 vaccine as a cause of human brucellosis
Company
The Lancet
Location
Iran
Seniority
Entry
Work Email
t***@thelancet.com
To:'s full work email still locked
Free account. Verified against live company records.
You'll unlock:
- To:'s full verified work email
- LinkedIn and full company profile
Colleagues at The Lancet
Other verified contacts at The Lancet.
Rhiannon HoweAssistant Editor at The LancetTed AlcornFreelance reporter at The LancetSheila PinionAssistant Editor at The LancetMelanie WulffSenior Editor at The LancetPam DasSenior Executive Editor at The LancetSonia HaerizadehResearcher, Commission on Migration and Health at The LancetMatej PharmdReviewer at The LancetStuart SpencerExecutive Editor at The Lancet
Frequently asked
What is To: Arfaa's email address?
To: Arfaa's work email follows the pattern t***@thelancet.com. Reveal it free.
What does To: Arfaa do?
To: Arfaa is the Brucella melitensis Rev-1 vaccine as a cause of human brucellosis at The Lancet.
Who is the Brucella melitensis Rev-1 vaccine as a cause of human brucellosis at The Lancet?
To: Arfaa.
Get To: Arfaa's verified contact details
Reveal the full work email and more. Free to start.
Try ScraperCity Free →